DK0812844T3 - Anvendelse af theophyllinderivater til behandling og profylakse af choktilstande, nye xanthinforbindelser og fremgangsmåder til deres fremstilling - Google Patents

Anvendelse af theophyllinderivater til behandling og profylakse af choktilstande, nye xanthinforbindelser og fremgangsmåder til deres fremstilling

Info

Publication number
DK0812844T3
DK0812844T3 DK97108870T DK97108870T DK0812844T3 DK 0812844 T3 DK0812844 T3 DK 0812844T3 DK 97108870 T DK97108870 T DK 97108870T DK 97108870 T DK97108870 T DK 97108870T DK 0812844 T3 DK0812844 T3 DK 0812844T3
Authority
DK
Denmark
Prior art keywords
prophylaxis
preparation
treatment
methods
shock conditions
Prior art date
Application number
DK97108870T
Other languages
Danish (da)
English (en)
Inventor
Hiristo Db Anagnostopulos
Ulrich Dr Gebert
Elisabeth Dr Defossa
Uwe Dr Heinelt
Erhard Dr Wolf
Karl Dr Rudolphi
John J Dr Grome
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19622737A external-priority patent/DE19622737A1/de
Priority claimed from DE1996129815 external-priority patent/DE19629815A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0812844T3 publication Critical patent/DK0812844T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97108870T 1996-06-07 1997-06-03 Anvendelse af theophyllinderivater til behandling og profylakse af choktilstande, nye xanthinforbindelser og fremgangsmåder til deres fremstilling DK0812844T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19622737A DE19622737A1 (de) 1996-06-07 1996-06-07 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung
DE1996129815 DE19629815A1 (de) 1996-07-24 1996-07-24 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
DK0812844T3 true DK0812844T3 (da) 2003-02-17

Family

ID=26026372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97108870T DK0812844T3 (da) 1996-06-07 1997-06-03 Anvendelse af theophyllinderivater til behandling og profylakse af choktilstande, nye xanthinforbindelser og fremgangsmåder til deres fremstilling

Country Status (26)

Country Link
US (1) US6214992B1 (es)
EP (1) EP0812844B1 (es)
JP (1) JP4156687B2 (es)
KR (1) KR100477177B1 (es)
CN (1) CN1066146C (es)
AR (1) AR007506A1 (es)
AT (1) ATE226583T1 (es)
AU (1) AU712277B2 (es)
BR (1) BR9703499A (es)
CA (1) CA2207120C (es)
CZ (1) CZ292205B6 (es)
DE (1) DE59708533D1 (es)
DK (1) DK0812844T3 (es)
ES (1) ES2185837T3 (es)
HU (2) HU224958B1 (es)
ID (1) ID19469A (es)
IL (1) IL120997A (es)
MX (1) MX9704203A (es)
MY (1) MY117910A (es)
NO (1) NO312400B1 (es)
NZ (1) NZ328017A (es)
PL (1) PL186576B1 (es)
PT (1) PT812844E (es)
RU (1) RU2201930C2 (es)
SI (1) SI0812844T1 (es)
TW (1) TW520285B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2804867B1 (fr) * 2000-02-15 2002-09-20 Hoechst Marion Roussel Inc Application de derives de xanthine pour la preparation d'un medicament destine a la prevention ou au traitement de l'osteoporose
UA80258C2 (en) * 2001-09-06 2007-09-10 Biogen Inc Methods of treating pulmonary disease
CN101538224A (zh) * 2002-05-31 2009-09-23 先灵公司 制备黄嘌呤磷酸二酯酶v抑制剂及其前体的方法
SI1509525T1 (sl) * 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
CN112500413B (zh) * 2020-10-13 2024-03-01 安徽中医药大学 一类黄嘌呤芳酸醚衍生物，其制备方法及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735898A (en) 1985-07-16 1988-04-05 The University Of Virginia Alumini Patents Foundation Monoclonal antibodies and method of identifying species using the same
US4904472A (en) * 1987-04-10 1990-02-27 The University Of Virginia Alumni Patent Foundation Use of adenosine antagonists in the treatment of bradyarrhythmias and mechanical dysfunction associated with cardiopulmonary resuscitation
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
JPH03167186A (ja) * 1989-11-24 1991-07-19 Hokuriku Seiyaku Co Ltd キサンチン誘導体及びその用途
US5036683A (en) * 1990-06-04 1991-08-06 Geuvjehizian Moushegh Y Steering wheel lock protector
DE4019571A1 (de) 1990-06-20 1992-01-02 Hoechst Ag Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CN1066146C (zh) 2001-05-23
CA2207120C (en) 2007-05-08
IL120997A (en) 2001-06-14
HUP9701016A3 (en) 2004-11-29
EP0812844A3 (de) 1998-04-08
BR9703499A (pt) 1998-10-06
MY117910A (en) 2004-08-30
TW520285B (en) 2003-02-11
HU0500865D0 (en) 2005-11-28
IL120997A0 (en) 1997-11-20
HU224958B1 (en) 2006-04-28
PL186576B1 (pl) 2004-01-30
SI0812844T1 (en) 2003-02-28
RU2201930C2 (ru) 2003-04-10
PT812844E (pt) 2003-03-31
AR007506A1 (es) 1999-11-10
CZ174397A3 (en) 1997-12-17
CA2207120A1 (en) 1997-12-07
JP4156687B2 (ja) 2008-09-24
DE59708533D1 (de) 2002-11-28
EP0812844B1 (de) 2002-10-23
CN1169993A (zh) 1998-01-14
NZ328017A (en) 2001-05-25
JPH1059969A (ja) 1998-03-03
KR980008230A (ko) 1998-04-30
HU225040B1 (en) 2006-05-29
MX9704203A (es) 1998-04-30
NO972582L (no) 1997-12-08
PL320413A1 (en) 1997-12-08
AU712277B2 (en) 1999-11-04
ATE226583T1 (de) 2002-11-15
CZ292205B6 (cs) 2003-08-13
EP0812844A2 (de) 1997-12-17
NO972582D0 (no) 1997-06-06
HU9701016D0 (en) 1997-07-28
US6214992B1 (en) 2001-04-10
ES2185837T3 (es) 2003-05-01
NO312400B1 (no) 2002-05-06
KR100477177B1 (ko) 2005-09-30
ID19469A (id) 1998-07-16
HUP9701016A2 (hu) 1998-12-28
AU2469897A (en) 1997-12-11

Similar Documents

Publication Publication Date Title
NO941679D0 (no) Gallesyrederivater, fremgangsmåte for fremstilling og deres anvendelse
DK1076657T3 (da) Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
DK1757606T3 (da) Anvendelse af xanthinderivater som l gemidler samt fremgangsm de til deres fremstilling
DK188488D0 (da) Benzen-derivater med leukotrien-antagonistvirkning og fremgangsmaade til fremstilling af saadanne derivater
DK371389D0 (da) Substituerede aminomethyltetraliner og deres heterocycliske analoge, deres fremstilling og anvendelse
NO904921D0 (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
DK593983A (da) Carboxamidoderivater af 5h-1,3,4-thiadiazolo-(3,2-a)pyrimidiner og fremgangsmaade til fremstilling deraf
DK0426476T3 (da) Pyrimidinderivater, deres fremstilling og anvendelse
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
NO985307L (no) Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende
DK300688D0 (da) Heterocycliske hydroxyethylazolderivater, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse
DK0812844T3 (da) Anvendelse af theophyllinderivater til behandling og profylakse af choktilstande, nye xanthinforbindelser og fremgangsmåder til deres fremstilling
DK0983275T3 (da) Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
DK0782575T3 (da) Substituerede pyrazol-pyrazol-derivater, fremgangsmåde til deres fremsstilling samt deres anvendelse som midler med herbicid virkning
DK0492501T3 (da) Overfladeaktive triazinforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse
DK88989D0 (da) Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
NO934633D0 (no) Kondenserte, heterocykliske forbindelser, deres fremstilling og anvendelse
DK115288A (da) Pesticid anvendelse af 2-phenylimidazolderivater samt 2-phenyl-imidazolderivater og fremgangsmaader til deres fremstilling
NO922428D0 (no) Heterocykliske forbindelser med reninhemmende egenskaper,deres fremstilling og anvendelse
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
DK29691D0 (da) Mitomycinderivater med reduceret knoglemarvstoksicitet, fremgangsmaader til deres fremstilling samt anvendelse heraf
DK0888304T3 (da) Substituerede 3-aryl-3-carboxyalkylsusbstituerede glutarimider, fremgangsmåde til fremstilling heraf ved ringslutning af 4-aryl-4-cyanoheptandicarboxylsyrer og deres anvendelse til fremstilling af 3-aryl-3-hydroxyalkylpiperidiner
NO934881D0 (no) Benzotiazolderivater, fremgangsmaate for deres fremstilling og far masoeytisk preparat derav
NO975217D0 (no) Fremgangsmåte for fremstilling av polyglyceryl-aminer, de oppnådde aminer og deres derivater
DK382183A (da) I 6-stilling usubstituerede 7-oxo-4-oxa-diazabicyclo(3.2.0)hept-2-en-derivater, fremgangsmaader til deres fremstilling og deres anvendelse som mellemprodukter til fremstilling af beta-lactamantibiotika